Asset Search
Displaying all 6 assets.
-
Description Figure 3. Within-patient interferon activity levels before and 24 hours after the interferon beta-1a dose. A, Active or partial responders. B, Stable or good responders. The dashed lines highlight...
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title: -
Description Figure 5. Dependence between the T2 lesion volume on interferon inhibitory activity (IIA) levels and disease duration. The points represent the observed values of T2 lesion volume for each patient,...
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title: -
Description Figure 2. Interferon inhibitory activity (IIA) and soluble interferon-/ receptor (sIFNR) levels before and 24 hours after interferon beta-1a dosing. The IIA (A) and sIFNR (B) levels are shown...
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title: -
Description Figure 4. 2-Microglobulin levels before (lighter bars) and 24 hours after (darker bars) the interferon beta-1a dose in stable or good and active or partial responders. Error bars indicated standard...
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title: -
Description Table. Clinical, Demographic, and MRI Characteristics*
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title: -
Description Figure 1. Interferon inhibitory activity (IIA) and soluble interferon-/ receptor (sIFNR) levels before interferon beta dosing. The IIA (A) and sIFNR (B) levels are shown for controls (open...
Article Title: Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Publication Title:
Displaying all 6 assets.